Marker Therapeutics (MRKR) executive compensation, 2026 proxy

Juan Vera, President and Chief Executive Officer, was paid $741,190 in 2025, up 85% from $400,000 the year before.

Open MRKR in Gloom →
Marker Therapeutics' chart, financials and news, free in your browser.Open MRKR in Gloom →
Filed
March 20, 2026
Annual meeting
May 1, 2026
Pay year
2025
Named executives
1
CEO total pay
$741,190+85% vs prior year
2025 CEO Base Salary
$415,385Increased from $400,000 in 2024
2025 CEO Option Awards
$265,995Granted in lieu of annual incentive
CEO Target Annual Incentive
40%Percentage of annual base salary

How Vera was paid

$741,190 in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Named executive officers

ExecutiveTotal
Juan VeraPresident and Chief Executive Officer$741,190

What changed and why

  • $741KCEO Juan Vera received total compensation of $741,190 in 2025, an increase from $400,000 in 2024.
  • $400KBase salary for the CEO increased from $400,000 in 2024 to $415,385 in 2025.
  • $266KOption awards for 2025 totaled $265,995, reflecting grants issued in lieu of earned annual incentive compensation.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.